305 related articles for article (PubMed ID: 22306692)
1. A CD74-dependent MHC class I endolysosomal cross-presentation pathway.
Basha G; Omilusik K; Chavez-Steenbock A; Reinicke AT; Lack N; Choi KB; Jefferies WA
Nat Immunol; 2012 Feb; 13(3):237-45. PubMed ID: 22306692
[TBL] [Abstract][Full Text] [Related]
2. Parasite Manipulation of the Invariant Chain and the Peptide Editor H2-DM Affects Major Histocompatibility Complex Class II Antigen Presentation during Toxoplasma gondii Infection.
Leroux LP; Nishi M; El-Hage S; Fox BA; Bzik DJ; Dzierszinski FS
Infect Immun; 2015 Oct; 83(10):3865-80. PubMed ID: 26195549
[TBL] [Abstract][Full Text] [Related]
3. An invariant road to cross-presentation.
Duan F; Srivastava PK
Nat Immunol; 2012 Feb; 13(3):207-8. PubMed ID: 22344275
[No Abstract] [Full Text] [Related]
4. Control of dendritic cell cross-presentation by the major histocompatibility complex class I cytoplasmic domain.
Lizée G; Basha G; Tiong J; Julien JP; Tian M; Biron KE; Jefferies WA
Nat Immunol; 2003 Nov; 4(11):1065-73. PubMed ID: 14566337
[TBL] [Abstract][Full Text] [Related]
5. N-terminal functional region of the invariant chain efficiently targets the binding of a CTL epitope to MHC class I molecules during cross-presentation.
Wu C; Zhang DG; Chen FF; Liu XL; Liu SJ; Yu WY
Genet Mol Res; 2014 Apr; 13(2):2438-50. PubMed ID: 24781998
[TBL] [Abstract][Full Text] [Related]
6. Differential use of autophagy by primary dendritic cells specialized in cross-presentation.
Mintern JD; Macri C; Chin WJ; Panozza SE; Segura E; Patterson NL; Zeller P; Bourges D; Bedoui S; McMillan PJ; Idris A; Nowell CJ; Brown A; Radford KJ; Johnston AP; Villadangos JA
Autophagy; 2015; 11(6):906-17. PubMed ID: 25950899
[TBL] [Abstract][Full Text] [Related]
7. The invariant chain transports TNF family member CD70 to MHC class II compartments in dendritic cells.
Zwart W; Peperzak V; de Vries E; Keller AM; van der Horst G; Veraar EA; Geumann U; Janssen H; Janssen L; Naik SH; Neefjes J; Borst J
J Cell Sci; 2010 Nov; 123(Pt 21):3817-27. PubMed ID: 20971706
[TBL] [Abstract][Full Text] [Related]
8. Encounter with antigen-specific primed CD4 T cells promotes MHC class II degradation in dendritic cells.
Furuta K; Ishido S; Roche PA
Proc Natl Acad Sci U S A; 2012 Nov; 109(47):19380-5. PubMed ID: 23129633
[TBL] [Abstract][Full Text] [Related]
9. Expression of invariant chain (CD 74) and major histocompatibility complex (MHC) class II antigens in the human fetus.
Badve S; Deshpande C; Hua Z; Lögdberg L
J Histochem Cytochem; 2002 Apr; 50(4):473-82. PubMed ID: 11897800
[TBL] [Abstract][Full Text] [Related]
10. MHC class II-restricted antigen processing and presentation.
Pieters J
Adv Immunol; 2000; 75():159-208. PubMed ID: 10879284
[No Abstract] [Full Text] [Related]
11. The role of MHC class I recycling and Arf6 in cross-presentation by murine dendritic cells.
Montealegre S; Abramova A; Manceau V; de Kanter AF; van Endert P
Life Sci Alliance; 2019 Dec; 2(6):. PubMed ID: 31740564
[TBL] [Abstract][Full Text] [Related]
12. Redirecting soluble antigen for MHC class I cross-presentation during phagocytosis.
Hari A; Ganguly A; Mu L; Davis SP; Stenner MD; Lam R; Munro F; Namet I; Alghamdi E; Fürstenhaupt T; Dong W; Detampel P; Shen LJ; Amrein MW; Yates RM; Shi Y
Eur J Immunol; 2015 Feb; 45(2):383-95. PubMed ID: 25378230
[TBL] [Abstract][Full Text] [Related]
13. MHC class II presentation is controlled by the lysosomal small GTPase, Arl8b.
Michelet X; Garg S; Wolf BJ; Tuli A; Ricciardi-Castagnoli P; Brenner MB
J Immunol; 2015 Mar; 194(5):2079-88. PubMed ID: 25637027
[TBL] [Abstract][Full Text] [Related]
14. Distinct antigen uptake receptors route to the same storage compartments for cross-presentation in dendritic cells.
Ho NI; Camps MG; Garcia-Vallejo JJ; Bos E; Koster AJ; Verdoes M; van Kooyk Y; Ossendorp F
Immunology; 2021 Nov; 164(3):494-506. PubMed ID: 34110622
[TBL] [Abstract][Full Text] [Related]
15. Infection of mouse bone marrow-derived dendritic cells with recombinant adenovirus vectors leads to presentation of encoded antigen by both MHC class I and class II molecules-potential benefits in vaccine design.
Herrera OB; Brett S; Lechler RI
Vaccine; 2002 Dec; 21(3-4):231-42. PubMed ID: 12450698
[TBL] [Abstract][Full Text] [Related]
16. Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation.
Wälchli S; Kumari S; Fallang LE; Sand KM; Yang W; Landsverk OJ; Bakke O; Olweus J; Gregers TF
Eur J Immunol; 2014 Mar; 44(3):774-84. PubMed ID: 24293164
[TBL] [Abstract][Full Text] [Related]
17. Virus-encoded ectopic CD74 enhances poxvirus vaccine efficacy.
Walline CC; Deffit SN; Wang N; Guindon LM; Crotzer VL; Liu J; Hollister K; Eisenlohr LC; Brutkiewicz RR; Kaplan MH; Blum JS
Immunology; 2014 Apr; 141(4):531-9. PubMed ID: 24205828
[TBL] [Abstract][Full Text] [Related]
18. Tumor-specific CD4+ T cells are activated by "cross-dressed" dendritic cells presenting peptide-MHC class II complexes acquired from cell-based cancer vaccines.
Dolan BP; Gibbs KD; Ostrand-Rosenberg S
J Immunol; 2006 Feb; 176(3):1447-55. PubMed ID: 16424172
[TBL] [Abstract][Full Text] [Related]
19. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y
Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504
[TBL] [Abstract][Full Text] [Related]
20. MHC class II antigen presentation by dendritic cells regulated through endosomal sorting.
ten Broeke T; Wubbolts R; Stoorvogel W
Cold Spring Harb Perspect Biol; 2013 Dec; 5(12):a016873. PubMed ID: 24296169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
